1. Home
  2. ATHM vs KARD Comparison

ATHM vs KARD Comparison

Compare ATHM & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

HOLD

Current Price

$21.93

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$21.62

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ATHM
KARD
Founded
2008
N/A
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
ATHM
KARD
Price
$21.93
$21.62
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
717.7K
232.4K
Earning Date
05-07-2026
N/A
Dividend Yield
9.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.77
N/A
P/E Ratio
$12.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.57
$19.41
52 Week High
$29.92
$27.00

Technical Indicators

Market Signals
Indicator
ATHM
KARD
Relative Strength Index (RSI) 48.37 53.88
Support Level $20.75 $21.68
Resistance Level $22.47 $22.61
Average True Range (ATR) 0.74 1.40
MACD -0.12 0.12
Stochastic Oscillator 46.02 66.00

Price Performance

Historical Comparison
ATHM
KARD

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: